Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

P. Kolh | M. Mack | P. Serruys | H. Suryapranata | P. Harst | F. Mohr | F. Burzotta | K. Stangl | P. Jüni | D. Dudek | P. van der Harst | A. Bogers | M. Aschermann | T. Feldman | I. Préda | D. Holmes | N. Curzen | M. Näbauer | M. Morice | G. Guagliumi | S. Redwood | N. Verberkmoes | V. Thourani | A. Gershlick | M. Sabaté | J. Escaned | K. Oldroyd | G. Stefanini | Goran Olivecrona | P. den Heijer | D. Carrié | A. Chieffo | F. Zijlstra | J. Berland | K. Endresen | J. Ruiz-Nodar | G. Laufer | R. Kramer | B. De Bruyne | B. Bruyne | B. D. da Costa | A. Jeppsson | A. Kappetein | H. Eltchaninoff | S. Head | F. Beyersdorf | S. Sandner | E. Christiansen | A. Witkowski | K. Dawkins | M. Corbascio | Phillip A. Horwitz | T. Noack | A. Bochenek | A. Banning | C. Hagl | R. Stoler | P. MacCarthy | A. Ahlsson | S. Berti | I. Cruz González | S. Ensminger | A. Belder | D. Tchétché | J. Heiser | O. Darremont | A. D. de Belder | C. Stark | M. Mariani | E. Ståhle | I. Horváth | H. Reichenspurner | K. Barber | C. Knight | R. Zelman | I. Narbute | B. Nasseri | P. Vermeersch | N. Burke | M. Mooney | F. Casselman | H. Grubitzsch | M. Laine | T. Bilfinger | R. Ingemansson | C. Grothusen | M. Bentala | F. Akca | M. Milojevic | J. K. Buckner | L. Cannon | G. Berg | B. Drieghe | T. Szerafin | P. Davierwala | V. Legrand | S. James | D. Thuijs | U. Canosi | P. Heijer | I. Lang | M. Suttorp | A. Taussig | A. Krauze | Stefan R Kiesz | R. A. Stine | P. Ho | U. Hoppe | T. Mcgarry | B. D. Costa | Werner Schultz | M. Guber | Kevin Wolschleger | John C. Chen | G. Heyrich | P. Coelho | Reddy Guera | A. Spolaor | Scott K. Lucas | Kevin A. Accola | John D. Talbott | Chris Akins | W. Killinger | Ignacio Cruz González | B. Góra | Karl Hauptman | Thomas J. Bilfinger | Evald Høj Christiansen | G. Olivecrona | I. C. González | W. Schultz | P. Jüni | H. Reichenspurner | Kevin G. Wolschleger | Thomas Bilfinger | Michael J. Mack | A. Kappetein | Kevin A Accola | George P. Heyrich | B. de Bruyne

[1]  P. Serruys,et al.  Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study. , 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[2]  P. Serruys,et al.  PCI and CABG for Treating Stable Coronary Artery Disease: JACC Review Topic of the Week. , 2019, Journal of the American College of Cardiology.

[3]  Samin K. Sharma,et al.  Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study. , 2019, Journal of the American College of Cardiology.

[4]  Volkmar Falk,et al.  2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[5]  Volkmar Falk,et al.  2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European heart journal.

[6]  M. Jeong,et al.  10-Year Outcomes of Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease. , 2018, Journal of the American College of Cardiology.

[7]  G. Stone,et al.  Interpretation of results of pooled analysis of individual patient data – Authors' reply , 2018, The Lancet.

[8]  V. Fuster,et al.  Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data , 2018, The Lancet.

[9]  J. Hartikainen,et al.  Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial , 2016, The Lancet.

[10]  S. Pocock,et al.  Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. , 2016, The New England journal of medicine.

[11]  Jack L. Martin,et al.  Left Main Stenting in Comparison With Surgical Revascularization: 10-Year Outcomes of the (Left Main Coronary Artery Stenting) LE MANS Trial. , 2016, JACC. Cardiovascular interventions.

[12]  M. Mack,et al.  Causes of Death Following PCI Versus CABG in Complex CAD: 5-Year Follow-Up of SYNTAX. , 2016, Journal of the American College of Cardiology.

[13]  J. Iqbal,et al.  Comparison of intravascular ultrasound guided versus angiography guided drug eluting stent implantation: a systematic review and meta-analysis , 2015, BMC Cardiovascular Disorders.

[14]  E. Hannan,et al.  Everolimus-eluting stents or bypass surgery for multivessel coronary disease. , 2015, The New England journal of medicine.

[15]  A. Yeung,et al.  Trial of everolimus-eluting stents or bypass surgery for coronary disease. , 2015, The New England journal of medicine.

[16]  M. Mack,et al.  Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. , 2014, European heart journal.

[17]  M. Mack,et al.  Five-Year Outcomes in Patients With Left Main Disease Treated With Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Trial , 2014, Circulation.

[18]  P. Serruys,et al.  Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials , 2013, The Lancet.

[19]  S. Garcia,et al.  Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. , 2013, Journal of the American College of Cardiology.

[20]  M. Mack,et al.  Quantification of Incomplete Revascularization and its Association With Five-Year Mortality in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Trial Validation of the Residual SYNTAX Score , 2013, Circulation.

[21]  Antonio Colombo,et al.  Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial , 2013, The Lancet.

[22]  M. Mack,et al.  Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries. , 2012, JACC. Cardiovascular interventions.

[23]  M. Mack,et al.  Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[24]  B. Gersh,et al.  Ten-Year Follow-Up Survival of the Medicine, Angioplasty, or Surgery Study (MASS II): A Randomized Controlled Clinical Trial of 3 Therapeutic Strategies for Multivessel Coronary Artery Disease , 2010, Circulation.

[25]  M. Mack,et al.  Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial , 2010, Circulation.

[26]  U. Siebert,et al.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. , 2009, The New England journal of medicine.

[27]  Antonio Colombo,et al.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.

[28]  Jeffrey L. Anderson,et al.  2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[29]  B. Gersh,et al.  Five-Year Follow-Up of the Medicine, Angioplasty, or Surgery Study (MASS II): A Randomized Controlled Clinical Trial of 3 Therapeutic Strategies for Multivessel Coronary Artery Disease , 2007 .

[30]  Patrick W Serruys,et al.  The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. , 2006, American heart journal.

[31]  P. Serruys,et al.  The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. , 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[32]  B. Gersh,et al.  Methods of coronary revascularization--things may not be as they seem. , 2005, The New England journal of medicine.